期刊文献+

胰腺癌组织中ABCG2、MRP-1的表达及临床意义 被引量:1

The expression and clinical significance of ABCG2 and MRP-1 in pancreatic cancer tissue
下载PDF
导出
摘要 目的探讨胰腺癌组织中ABCG2和MRP-1的表达及其临床意义,为肿瘤筛查、抗癌药物选择及MDR抑制剂因子药物研究提供依据。方法用免疫组化方法研究98例胰腺组织中ABCG2、MRP-1的表达,应用SPSS软件分析二者表达与胰腺肿瘤患者的临床病理特征的关系。结果 ABCG2在胰腺癌、胰腺良性肿瘤及正常胰腺组织中的阳性率分别为53.62%、18.18%、16.67%,其在胰腺癌中表达较两对照组差异具统计学意义(P<0.05);而MRP-1在胰腺癌、胰腺良性肿瘤及正常胰腺组织中的阳性率分别为62.32%,18.18%,27.78%,其在胰腺癌中表达较两对照组差异同样存在计学意义(P<0.05);二者表达均与肿瘤大小相关,而MRP-1表达尚与肿瘤分化相关;在胰腺癌组织中ABCG2与MRP-1表达呈正相关(rs=0.489,P=0.044)。结论 ABCG2与MRP-1在胰腺癌组织中表达与肿瘤生长与分期相关,其表达对预后具有意义。 【Objective】To discuss the expression and clinical significance of ABCG2 and MRP-1 in pancreatic cancer tissue,which develop in the area of cancer screening,anti-cancer drug selection and the MDR inhibitor drugs research.【Methods】Use immunohistochemical methods to study ABCG2,MRP-1 expression in the pancreatic tissue,involved in 98 cases(69 cases of malignant tumors,11 benign and 18 cases of normal tissue),and analyze both expression and pancreatic cancer patients pathological features with SPSS software.【Resluts】ABCG2 positive rate of pancreatic cancer,pancreatic benign tumor and normal pancreatic tissue were 53.62%,18.18%,16.67%,the pancreatic expression compared with two control groups has statistically significant difference(P &lt;0.05);MRP-1 positive rate of pancreatic cancer,pancreatic benign tumor and normal pancreatic tissue were 62.32%,18.18%,27.78%,its count significance(P &lt;0.05) compared with two control groups;Both expression were cordianted with tumor size,MRP-1 expression is also cordianted with tumor differentiation;ABCG2 in pancreatic cancer tissues and MRP-1 expression was positively correlated(rs = 0.489,P = 0.044).【Conclusion】ABCG2 and MRP-1 expression in pancreatic carcinoma is associated with tumor growth and staging,which is meaningful in prognosis.
出处 《中国医学工程》 2013年第3期9-11,共3页 China Medical Engineering
关键词 胰腺癌 MDR 人类乳腺耐药相关蛋白(ABCG2) 多药耐药相关蛋白(MRP-1) 免疫组织化学 pancreatic cancer MDR ABCG2 MRP-1 immunohistochemical methods
  • 相关文献

参考文献11

  • 1Clayton H, Titley I, VivancoM.Growth and differentiation of p rogenitor/stem cells derived from the human mammary gland [J].Exp Cell Res,2004,297 (2) :444-460.
  • 2Summer R,Kotton D N,Sun X,et al.Side population celks and Bcrpl exp ression in lnng[J].Am J Physiol Lung Cell Mol Physiol,2003,285 (1) :97-104.
  • 3Monika Olempska,Patricia Alice Eisenach,Ole Ammerpohl,Hendrik Ungefroren,Fred Fandrich,Holger Kalthoff.Detection of tumor stem cell markers in pancreatic carcinoma cell lines[J].Hepatobiliary & Pancreatic Diseases International,2007,6(1):92-97. 被引量:69
  • 4Doyle LA, Yang W, Abruzzo LV, et al.A muhidrug resistance transporter from human MCF27 breast cancer cell[J].Proc Natl Acad Sci USA,1998,95 (26) :15665-15670.
  • 5Shin Hamada, Kennichi Satoh, Morihisa Hirota,et al.The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2[J].Journal of Cellular Physiology,2011,7:89.
  • 6Jorg konig,Mark hartel.Expression and localization of human muhidrug resistance protein (ABCC) family members in pancreatic carcinoma[J].Int J Cancer,2005,115:359-367.
  • 7LO Driscolll.MDR1 and MRP-1 Drug Efflux Pumps in Pancreatic Carcinoma[J].Int J Anti Cancer Reseach,2007,27:2115-2120.
  • 8张俊,朱正纲,刘风华,纪玉宝,刘炳亚,尹浩然,林言箴.MTT法检测94例胃癌体外药敏[J].上海医学,2002,25(4):241-243. 被引量:35
  • 9牛虹.PGP和MRP在食管贲门癌中的表达及意义,2006,5:99.
  • 10石晶,滕月娥,张敬东,金波,赵明芳,于萍,刘云鹏.乳腺癌组织中ABCG2和HIF-1α的表达及临床意义[J].中国医科大学学报,2008,37(5):697-700. 被引量:15

二级参考文献40

  • 1DOYLE LA,YANG W. A multidrug resistance transporter from human MCF-7 breast cancer cells[J].J Proc Natl Acad Sci USA, 1998,95(26) : 15665-15670.
  • 2ENOKIZONO J,KUSUHARA H. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect[J]. J Drug Metab Dispos,2007,35 (2) :209-214.
  • 3BENDERRA Z,FAUSSAT AM. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemis [J]. J Clin Cancer Res, 2004,10(23 ) : 7896-7902.
  • 4BURGER H,FOEKENS JA.RNA expression of breast cancer resistance protein,lung resistance-related protein,multidrug resistance-associated priteins 1 and 2,and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic [J ]. J Clin Cancer Res, 2003,9(2) : 827-836.
  • 5FANEYTE IF,KRISTEL PM. Expression of the breast cancer resistance protein in breast cancer [J]. J Clin Cancer Res,2002,8(4): 1068-1074.
  • 6KANZAKI A,TOI M. Expression of multidrug resistance-related transporters in human breast carcinoma [J]. J Jpn J Cancer Res, 2001,92(4): 452-458.
  • 7KRISHNAMURTHY P,SCHUETZ JD. Role of ABCG2/BCRP in biology and medicine[J]. J Ann Rev Pharmacol Toxicol,2006,46: 381-410.
  • 8EE PL,KAMALAKARAN S.Identification of a novel estrogen re sponse element in the breast cancer resistance protein (ABCG2) gene[J]. J Cancer Res,2004,64(4): 1247-1251.
  • 9Kondo T;Setoguchi T;Tags T.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line,2004(03).
  • 10Yin AH;Miraglia S;Zanjani ED.AC133, a novel marker for human hematopoietic stem and progenitor cells,1997.

共引文献116

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部